Today: September 30, 2024
Today: September 30, 2024

Latest From Reuters

Business|Economy|Health

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France
Health

Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows

About one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight loss and related conditions, a poll by Kaiser Family Foundation (KFF) showed on Friday.

Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows
Health

Pfizer agrees to settle over 10,000 Zantac lawsuits, Bloomberg News reports

Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar

Pfizer agrees to settle over 10,000 Zantac lawsuits, Bloomberg News reports
Environment|Health

EU Commission eyeing exemptions for 'forever chemicals' ban, letter shows

The European Commission is planning to allow exemptions from a proposed ban on substances known as PFAS, or "forever chemicals", to

EU Commission eyeing exemptions for 'forever chemicals' ban, letter shows
Business|Economy|Health

Tylenol maker Kenvue to cut 4% jobs, beats quarterly profit estimates

Kenvue will cut 4% of its global workforce amid investments to grow its key brands, the Tylenol and Band-Aid maker said on Tuesday, as it topped beat Wall Street estimates for first-quarter

Tylenol maker Kenvue to cut 4% jobs, beats quarterly profit estimates
Business|Health

Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments

Vertex Pharmaceuticals beat Wall Street estimates for first-quarter profit on Monday, driven by robust uptake for its blockbuster cystic fibrosis treatments.

Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments
Business|Economy|Health

China offers flexible jobs for women after childbirth

Chinese provinces are urging companies to offer women flexible job roles called "Mama's Posts" that make it easier to balance work and childcare, the official Xinhua news agency

China offers flexible jobs for women after childbirth
Business|Health

KKR to buy India's Healthium Medtech at $839 million valuation, sources say

Global investment firm KKR will buy Indian medical devices maker Healthium Medtech from UK-based Apax Partners in a deal that three sources with direct knowledge of the

KKR to buy India's Healthium Medtech at $839 million valuation, sources say
Business|Health

Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data

Shares in Danish drugmaker Novo Nordisk dropped as much as 5.3% on Friday, set for their biggest one-day fall since August 2022, after rival Amgen said it was encouraged by interim trial

Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data
Business|Economy|Health

Illumina reaffirms annual revenue forecast over continued sluggish demand

Illumina reiterated its 2024 revenue forecast on Thursday, expecting continued weak demand from its customers such as medical research labs and hospitals.

Illumina reaffirms annual revenue forecast over continued sluggish demand
Business|Health

Sanofi to overhaul US operations of vaccines, cut jobs

French drugmaker Sanofi said on Thursday it would restructure the U.S. com­mer­cial op­er­a­tions for its vac­cines and cut an undis­closed num­ber of jobs.

Sanofi to overhaul US operations of vaccines, cut jobs
Business|Health

Zimmer Biomet beats Q1 profit estimates on robust demand for knee, hip devices

Medtech firm Zimmer Biomet Holdings beat Wall Street estimates for first-quarter profit on Thursday, on the back of robust demand for its devices that are used in knee and hip

Zimmer Biomet beats Q1 profit estimates on robust demand for knee, hip devices
Business|Economy|Health

Regeneron's blockbuster eye drug posts weaker sales due to inventory impact

U.S. drugmaker Regeneron Pharmaceuticals Inc missed Wall Street estimates for quarterly profit on Thursday, hurt by softer sales of its blockbuster eye drug Eylea due to reduction in

Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
Business|Economy|Health

Sensodyne-maker Haleon posts tepid sales as demand for some products cool off

Consumer healthcare company Haleon reported first-quarter revenue slightly below market estimates on Wednesday, as volumes declined due to retailer destocking in U.S. and cooling demand for

Sensodyne-maker Haleon posts tepid sales as demand for some products cool off
Business|Economy|Health

Sanofi profit slips on generic competition and currency effects

Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-

Sanofi profit slips on generic competition and currency effects
Business|Health

GE HealthCare misses quarterly revenue estimates on weakness in China market

GE HealthCare Technologies missed first-quarter revenue estimates on Tuesday, hurt by lower sales in China market and weaker-than-expected demand for its scanning devices, sending its

GE HealthCare misses quarterly revenue estimates on weakness in China market
Economy|Health

Insurer Humana pulls 2025 profit forecast on disappointing Medicare rates

Humana withdrew its already downscaled 2025 profit forecast on Wednesday, citing disappointing government Medicare reimbursement rates, sending the health

Insurer Humana pulls 2025 profit forecast on disappointing Medicare rates
Economy|Europe|Political

UK PM Starmer says cost of fixing public finances will be shared fairly

British Prime Minister Keir Starmer said on Tuesday that the cost of fixing shortfalls in the public finances would be shared fairly and that all his government's

UK PM Starmer says cost of fixing public finances will be shared fairly
Americas|Crime|Political

Florida will investigate gunman on Trump golf course, Governor DeSantis says

Florida will investigate the apparent attempted assassination of Republican presidential candidate Donald Trump at his West Palm Beach golf course, Florida Governor Ron DeSantis

Florida will investigate gunman on Trump golf course, Governor DeSantis says
Europe|Political

Ukraine disappointed at Slovak PM's fascism comments

Ukraine on Monday expressed disappointment at allegations by Slovakia's pro-Russian prime minister that Kyiv should act to remove from its military ranks what he described as fascist

Ukraine disappointed at Slovak PM's fascism comments
Americas|Political

Honduran president faces call to resign as video scandal intensifies

A leading anti-corruption activist called on Honduran President Xiomara Castro on Wednesday to resign after a video surfaced that appeared to show her brother-in-law

Honduran president faces call to resign as video scandal intensifies
Election|Europe|Political

Germany's far-right AfD set to come first in Thuringia election - exit poll

Germany's far-right AfD was on track to coming first in the state election of Thuringia on Sunday, an exit poll by broadcaster ZDF said, although it will unlikely be able to form a

Germany's far-right AfD set to come first in Thuringia election - exit poll
Europe|Political

Poland seeks to strip immunity from ex-PM's top aide

Poland's Prosecutor General has asked the President of the European Parliament to consent to prosecuting Michal Dworczyk, a European Union lawmaker and right-hand man of former

Poland seeks to strip immunity from ex-PM's top aide
Asia|Political

Indonesia's anti-graft body plans to query president's son about private jet trip

JAKARTA - Indonesia's anti-graft agency plans to ask the youngest son of President Joko "Jokowi" Widodo to clarify his use of a private jet on a recent overseas trip as well as who paid for the travel

Indonesia's anti-graft body plans to query president's son about private jet trip
Business|Economy|Europe|Political

Berlin defence strategy eyes stakes in arms companies, report says

The German government could take a stake in arms-makers and defence projects in "strategic cases", according to a draft paper written by the economy and defence ministries, the

Berlin defence strategy eyes stakes in arms companies, report says

Follow